NEJM AI Grand Rounds From Bedside to Boardroom: How AI, Multi-Omics, and New Business Models Are Shaping the Biomedical Frontier with Morgan Cheatham
44 snips
Mar 19, 2025 Morgan Cheatham, a venture capitalist at Bessemer and a medical student at Brown, dives into the intersection of AI and genomic medicine. He reveals how AI is revolutionizing clinical documentation and decision-making, making medicine more precise. Morgan shares insights from his research on ChatGPT's USMLE performance and discusses the hurdles of outdated payment models in healthcare. His journey highlights the blend of medical training and venture capital, emphasizing that innovation must be supported by sustainable business strategies.
AI Snips
Chapters
Transcript
Episode notes
Formative Experiences
- Morgan Cheatham's interest in medicine started early, but his path was shaped by witnessing Epic implementation chaos.
- He designed a major around computational decision sciences, combining economics, computer science, and neuroscience.
ChatGPT and the USMLE
- Morgan Cheatham published a seminal paper on ChatGPT's performance on the USMLE while still a first-year medical student.
- This work highlighted the potential of AI in medical education and sparked a broader discussion.
The Role of Information Gathering
- Consider the physician’s role as an information gatherer when evaluating AI in healthcare.
- Future studies should compare AI’s diagnostic ability with a human physician's, given the same patient-gathered information.